Cortechs.ai | Understanding the Hippocampal Occupancy Score

Understanding the Hippocampal Occupancy Score

One of the most frequently asked questions among Cortechs.ai customers is, “What does the Hippocampal Occupancy Score (HOC) represent within the NeuroQuant Dementia: Age-Related Atrophy report? 

The NeuroQuant Dementia: Age-Related Atrophy report presents volumetric information on brain structures relevant to Alzheimer’s disease and dementia, as well as their normative comparison to age and gender-matched reference data. The structures in this report include the hippocampus, superior and inferior lateral ventricles, entorhinal cortex, lobar cortices, anterior cingulate, and posterior cingulate. The clinical utility of this report lies in determining atrophic patterns that may be attributed to certain types of dementia. For example, preserved hippocampal volumes alongside reduced frontal and temporal lobe volumes may signify frontotemporal dementia. Diminished hippocampal volumes in the presence of statistically significant inferior lateral ventricle enlargement could indicate the presence of Alzheimer’s disease, when considering additional clinical factors. 

The HOC score, as part of the NeuroQuant Dementia: Age-Related Atrophy report, takes dementia analysis a step further. The HOC score can help identify progression from mild cognitive impairment (MCI) to Alzheimer’s disease. 

What is the HOC score? 

The HOC score is a calculated metric used to estimate mesial temporal lobe atrophy based on inferior lateral ventricle expansion.  

Essentially, it is a ratio of the hippocampal volumes to the inferior lateral ventricle + hippocampal volumes:

HOC = Hippocampal Volume / (Hippocampal Volume + ILV Volume) 

Since Alzheimer’s disease typically begins with hippocampal breakdown (responsible for memory loss) and compensatory inferior later ventricle expansion (ex-vacuo dilatation), a low HOC score can signify the likelihood of Alzheimer’s disease progression. 

Where can I visualize the HOC score? 

The HOC score is visualized in the Brain Structure Volumes Table in the Dementia: Age-Related Atrophy report. The HOC value is given in the “Volume” column, while the comparison to age and gender- matched norms is given in the “Normative Percentile” column. 

Cortechs.ai | Understanding the Hippocampal Occupancy Score

Case Examples: Clinical Relevance of the HOC score

Case 1: 75-Year- Old Female

Cortechs.ai | Understanding the Hippocampal Occupancy Score

 

  • HOC:68
  • Volumetric Findings:
    • Hippocampi:12cm3, 1st normative percentile
    • ILV: 94cm3, 50th normative percentile
  • Conclusion: Volumetric analysis does not support mesial temporal lobe atrophy with ex-vacuo dilatation. Possible congenitally small hippocampus.

Case 2: 58-Year Old Female

Cortechs.ai | Understanding the Hippocampal Occupancy Score

  • HOC: 5
  • Volumetric Findings:
    • Hippocampi:75cm3, 1st normative percentile
    • ILV:92cm3, 99th normative percentile
  • Conclusion: Volumetric analysis demonstrates low normative volumes in the mesial temporal lobe with high normative volumes of the inferior lateral ventricles. This could signify ex vacuo dilatation consistent with Alzheimer’s disease progression.

Case 3: 70-Year-Old Female 

Cortechs.ai | Understanding the Hippocampal Occupancy Score

  • HOC: 0.73 
  • Volumetric Findings: 
    • Hippocampi: 5.58cm3, 26th normative percentile 
    • ILV: 2.07cm3, 63rd normative percentile 
  • Conclusion: Volumetric analysis demonstrates hippocampal and inferior lateral ventricle volumes that are within normal limits for patient age and sex. No evidence of mesial temporal lobe atrophy. 

More Resources

11/17/2025

Unlocking the Value of NeuroQuant Reports: Different Use Cases Across Clinical Practice

From neurodegeneration and demyelination to development, trauma, and seizures, NeuroQuant supports better decision‑making, communication, and patient care

11/17/2025

Case Study: Augmenting Prostate Imaging Programs with OnQ™ Prostate

Discover how Imaging Healthcare Specialists integrated OnQ™ Prostate to enhance lesion visibility, boost diagnostic confidence, and improve communication.

11/04/2025

NeuroQuant Dementia in Different Use Cases 

NeuroQuant transforms brain imaging into a measurable biomarker for neurodegeneration by combining volumetric data with clinical expertise.

10/29/2025

Enhancing Brain Tumor Treatment with RT STRUCT Images: The Promise of Automation

Automating the generation of RT STRUCT images with NeuroQuant Brain Tumor can streamline workflows and elevate the standard of care

10/15/2025

Sharper Screening, Smarter Biopsies: OnQ Prostate and the Next Step in Imaging

Read to learn how OnQ Prostate goes beyond existing solutions like DynaCAD and redefines biopsy precision

10/14/2025

Cortechs.ai Acquires ZepMed to Expand AI-Powered Neuroimaging Capabilities

This strategic acquisition strengthens Cortechs.ai’s position at the forefront of radiological innovation and expands its suite of best-in-class solutions
Scroll to Top